Dr Nevil Chimon
Dr Nevil Chimon is a medical science graduate of UCLAN, BSc (Hons), Manchester University, MSc & NUS, PhD, with Post-Doctoral training in Molecular Imaging & Radiochemistry completed at the Paterson Institute for Cancer Research & Wolfson Molecular Imaging Centre, UK. Nevil has over 10 years of experience within the pharmaceuticals industry. Holding positions of increasing responsibility within MNCs and SMEs has provided him with broad exposure to projects involving drug discovery & imaging diseases, including cancer & dementia. Strategically, he recognizes an opportunity exists to leverage on molecular imaging technology to both accelerate drug discovery and improve the healthcare of patients by using PET-CT and PET-MRI multi-modality imaging. During his 7-years based in Singapore, Dr Chimon has established the first Preclinical CRO imaging facility, obtained GMP licensing for the RadLink cyclotron facility, performed the first clinical trial with a proprietary radiotracer for Bayer Pharmaceuticals, & manufactured new tracers to detect cancer.
